Beranda8AK • FRA
add
Alkermes Plc
Tutup sebelumnya
€22,40
Rentang hari
€22,20 - €22,20
Rentang tahun
€22,20 - €34,60
Kapitalisasi pasar
4,45 M USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 306,51 jt | -12,52% |
Biaya operasional | 243,52 jt | -1,97% |
Laba bersih | 22,46 jt | -39,00% |
Margin laba bersih | 7,33 | -30,26% |
Penghasilan per saham | 0,29 | -32,33% |
EBITDA | 21,21 jt | -58,70% |
Tarif pajak efektif | 11,87% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 884,02 jt | 18,65% |
Total aset | 2,08 M | -1,97% |
Total liabilitas | 570,39 jt | -34,37% |
Total ekuitas | 1,51 M | — |
Saham yang beredar | 164,90 jt | — |
Harga terhadap nilai buku | 2,44 | — |
Tingkat pengembalian aset | 1,67% | — |
Tingkat pengembalian modal | 2,21% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 22,46 jt | -39,00% |
Kas dari operasi | 98,81 jt | 368,12% |
Kas dari investasi | 9,10 jt | 122,78% |
Kas dari pembiayaan | 747,00 rb | 104,18% |
Perubahan kas bersih | 108,66 jt | 395,95% |
Arus kas bebas | 75,80 jt | 536,44% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
1.800
